Biotech Barbell: The Best Way to Invest in a “Risky” Sector
Investing in a segment like biotech doesn’t have to feel risky. The “barbell” strategy creates a balance between high- and low-risk assets.
Posted by Adam O'Dell | May 21, 2021 | Investing
Investing in a segment like biotech doesn’t have to feel risky. The “barbell” strategy creates a balance between high- and low-risk assets.
Posted by Adam O'Dell | May 18, 2021 | Markets
The DNA revolution is here, and I think it has the potential to be more impactful than the internet across multiple stock sectors.
Posted by Adam O'Dell | May 17, 2021 | Investing
A stock’s size factor relates to its market capitalization, and it explains in part how smaller companies can lead to huge stock market gains.
Posted by Adam O'Dell | May 10, 2021 | Markets
You might be wondering what President Biden’s capital gains tax would do to the stock market. Here’s how I think big investors will react.
Posted by Adam O'Dell | May 3, 2021 | Investing
No one can pinpoint exactly where the inflation rate is going, but this ETF is the perfect fund to ride the wave up — or down.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below